(Q35094863)

6 August 2017

1 reference

title

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study (English)

1 reference

6 August 2017

Anthony D Booth

1

1 reference

6 August 2017

Mike K Almond

2

1 reference

6 August 2017

Aine Burns

3

1 reference

6 August 2017

Peter Ellis

4

1 reference

6 August 2017

Gill Gaskin

5

1 reference

6 August 2017

Guy H Neild

6

1 reference

6 August 2017

Martin Plaisance

7

1 reference

6 August 2017

Charles D Pusey

8

1 reference

6 August 2017

David R W Jayne

9

1 reference

6 August 2017

Pan-Thames Renal Research Group

10

1 reference

6 August 2017

publication date

1 April 2003

1 reference

American Journal of Kidney Diseases

6 August 2017

published in

1 reference

6 August 2017

volume

41

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

776-784

1 reference

New findings in pathogenesis of antineutrophil cytoplasm antibody-associated vasculitis

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Epidemiology of vasculitis in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

The spectrum of renal disease associated with microscopic polyangiitis and classic polyarteritis nodosa in Kuwait.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Brother and sister with myeloperoxidase associated autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

A familial case of P-ANCA glomerulonephritis presenting in a father and daughter

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Familial occurrence of systemic vasculitis and rapidly progressive glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

ANCA-associated vasculitis in Greek siblings with chronic exposure to silica

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Fcgamma receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Neutrophil FcgammaRIIIb allelic polymorphism in anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

No association between neutrophil FcgammaRIIa allelic polymorphism and anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

The role of metals in autoimmune vasculitis: epidemiological and pathogenic study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Silicon exposure and vasculitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

ANCA-associated diseases and silica exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Wegener Granulomatosis: An Analysis of 158 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Antiproteinase 3- and antimyeloperoxidase-associated vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Wegener's granulomatosis: clinical course in 108 patients with renal involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Wegener's granulomatosis in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Evidence-based treatment of systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Safety and efficacy of TNFalpha blockade in relapsing vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900025-8

7 January 2021

10.1016/S0272-6386(03)00025-8

Identifiers

DOI

1 reference

6 August 2017

1 reference